RANI as of Oct 31 · 19:01 ET
RANINasdaqPharmaceutical Preparations

Rani Therapeutics Holdings, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±35.6%▼−0.23%×0.01
quarterimplied−40%0+40%realized×
Q2 FY26±35.6%▼−0.23%×0.01
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

8disclosed supplier and customer ties in SEC filingsSEC filings
67managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

7managers whose positions together make up four fifths of reported value13F · Jun 30 '26
3 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

RANI report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 23impliedImplied move: ±66.1% into Nov 5 earnings (Oct 23 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.